DATATRAK International Reports First Quarter Result...( CLEVELAND May 8 /- DATATRAK Inter...),Health

CLEVELAND, May 8 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (Nasdaq: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today reported its operating results for the first quarter of 2008.

For the three months ended March 31, 2008, revenue decreased approximately 41% to $2,088,000 and the Company reported a net loss of $(2,233,000), or $(0.16) per share on both a basic and diluted basis. These results compared with revenue of $3,542,000 and a net loss of $(1,895,000) or $(0.16) per share on both a basic and diluted basis in the first quarter of 2007.

The gross profit margin for the first quarter was 55% compared to 62% for the same period a year ago. The decline in gross profit margin was a result of the 41% decrease in revenue partially offset by a 30% reduction in direct costs.

DATATRAK's backlog at March 31, 2008 was $13.9 million and backlog currently stands at approximately $12.9 million. This compares to a backlog of $13.0 million at December 31, 2007. Backlog is defined as the remaining value of signed contracts or authorization letters to commence services. The Company does not include in its backlog potential contracts or authorization letters that have passed the verbal stage, but have not been signed. All contracts are subject to possible delays or cancellation or can change in scope in a positive or negative direction. Therefore, current backlog is not necessarily indicative of the Company's future quarterly or annual revenue. Historically, backlog has been a poor predictor of the Company's short-term revenue.

"In our last financial release and conference call in late February we stated that we were seeing early signs of a buil
'/>"/>